Tag: Xolair® (omalizumab)
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...
Assessment for both single agent and add-on therapy.
Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis
Small study finds drug may be effective in treating IA.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
Must See: 'ViewFinder: Food for Thought – Food Allergies'
This documentary should be required viewing for everyone as the food allergy epidemic has affected so many in the community.
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...
Patients reached full tolerance for 70.4% of the tested foods which were reintroduced to the patients’ diet without the need for OIT.
Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...
"We discovered that preventing infant mice from creating antibodies would effectively diminish the risk of allergies in their adult lives."
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Study: Drug Increases Speed and Safety of OIT for Multiple Allergies
Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy
The technique could also be applied to other IgE-mediated food allergies.
